Preview

Педиатрическая фармакология

Расширенный поиск

Функциональные расстройства органов пищеварения у детей: отдаленные последствия и современные возможности предупреждения и коррекции

https://doi.org/10.15690/pf.v14i5.1788

Полный текст:

Аннотация

В статье обсуждаются современные представления о генезе наиболее распространенных вариантов функциональных расстройств органов пищеварения у детей, в том числе их долгосрочные негативные последствия для здоровья ребенка. Представлены данные о роли кишечной микробиоты в формировании функциональных расстройств органов пищеварения, а также современные подходы к их предупреждению и коррекции с помощью пробиотиков с доказанной эффективностью.



Об авторах

Е. Г. Макарова
ООО «Нестле Россия», Москва
Россия
гиевна, кандидат медицинских наук, медицинский научный советник


С. Е. Украинцев
ООО «Нестле Россия», Москва; Национальный медицинский исследовательский центр здоровья детей, Москва, Российская Федерация
Россия


Список литературы

1. Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):237–241.

2. Drossman DА, Richer JE, Talley N, editors. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment. A multinational consensus. Boston: Little, Brown & Co; 1994. 370 p.

3. Бельмер С.В., Гасилина Т.В., Хавкин А.И., Эйберман А.С. Функциональные нарушения органов пищеварения у детей. — М.; 2005. — 36 с. [Bel’mer SV, Gasilina TV, Khavkin AI, Eiberman AS. Funktsional’nye narusheniya organov pishchevareniya u detei. Moscow; 2005. 36 p. (In Russ).]

4. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6(5):306–314. doi: 10.1038/nrgastro.2009.35.

5. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuro-endocrine factors and stress. J Psychosom Res. 2002;53(4):865–871. doi: 10.1016/S0022-3999(02)00429-4.

6. Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146(6):1500–1512. doi: 10.1053/j.gastro.2014.02.037.

7. Хавкин А.И., Жихарева Н.С. Подходы к лечению синдрома раз-драженного кишечника у детей // Вопросы современной педиатрии. — 2004. — Т.3. — №2 — С. 30–34. [Khavkin AI, Zhihareva NS. Different approaches to treatment of irritable bowel syndrome in children. Current pediatrics. 2004;3(2):30–34. (In Russ).]

8. Partty A, Kalliomaki M, Salminen S, Isolauri E. Infant distress and development of functional gastrointestinal disorders in childhood: is there a connection? JAMA Pediatr. 2013;167(10):977–978. doi: 10.1001/jamapediatrics.2013.99.

9. Savino F, Castagno E, Bretto R, et al. A prospective 10-year study on children who had severe infantile colic. Acta Paediatr Suppl. 2005;94(449):129–132. doi: 10.1080/08035320510043691.

10. Romanello S, Spiri D, Marcuzzi E, et al. Association between childhood migraine and history of infantile colic. JAMA. 2013;309(15):1607– 1612. doi: 10.1001/jama.2013.747.

11. Canivet C, Jakobsson I, Hagander B. Infantile colic. Follow-up at four years of age: still more “emotional”. Acta Paediatr. 2000;89(1):13–17. doi: 10.1080/080352500750028988.

12. Rautava P, Lehtonen L, Helenius H, Sillanpaa M. Infantile colic: child and family three years later. Pediatrics. 1995;96(1 Pt 1):43–47.

13. Wolke D, Rizzo P, Woods S. Persistent infant crying and hyperactivity problems in middle childhood. Pediatrics. 2002;109(6):1054– 1060. doi: 10.1542/peds.109.6.1054.

14. Rao MR, Brenner RA, Schisterman EF, et al. Long term cognitive development in children with prolonged crying. Arch Dis Child. 2004;89(11):989–992. doi: 10.1136/adc.2003.039198.

15. Wolke D, Schmid G, Schreier A, Meyer R. Crying and feeding problems in infancy and cognitive outcome in preschool children born at risk: a prospective population study. J Dev Behav Pediatr. 2009;30(3):226–238. doi: 10.1097/DBP.0b013e3181a85973.

16. Brown M, Heine RG, Jordan B. Health and well-being in school-age children following persistent crying in infancy. J Paediatr Child Health. 2009;45(5):254–262. doi: 10.1111/j.1440-1754.2009.01487.x.

17. Сорвачева Т.Н., Пашкевич В.В. Функциональные нарушения ЖКТ у грудных детей: методы коррекции // Лечащий врач. — 2006. — №4 — С. 40–46. [Sorvacheva TN, Pashkevich VV. Funktsional’nye narusheniya ZhKT u grudnykh detei: metody korrektsii. Practitioner. 2006;(4):40–46. (In Russ).]

18. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109(6):1061–1067. doi: 10.1542/peds.109.6.1061.

19. Loening-Baucke V. Constipation in early childhood: patient characteristics, treatment, and longterm follow up. Gut. 1993;34(10):1400– 1404. doi: 10.1136/gut.34.10.1400.

20. Molloy CA, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism. 2003;7(2):165–171. doi: 10.1177/1362361303007002004.

21. Niehus R, Lord C. Early medical history of children with autism spectrum disorders. J Dev Behav Pediatr. 2006;27(2):S120–127. doi: 10.1097/00004703-200604002-00010.

22. Valicenti-McDermott M, McVicar K, Rapin I, et al. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. 2006;27(2 Suppl):S128–136. doi: 10.1097/00004703-200604002-00011.

23. McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133(5):872–883. doi: 10.1542/peds.2013-3995.

24. Foster J, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305– 312. doi: 10.1016/j.tins.2013.01.005.

25. Naseribafrouei A, Hestad K, Avershina E, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155–1162. doi: 10.1111/nmo.12378.

26. Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays. 2014;36(10):933– 939. doi: 10.1002/bies.201400075.

27. Song YL, Liu CX, Finegold SA. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004;70(11):6459– 6465. doi: 10.1128/Aem.70.11.6459-6465.2004.

28. Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62(1):159–176. doi: 10.1136/gutjnl-2012-302167.

29. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–396. doi: 10.1146/annurev-med-012309-103958.

30. Berrill JW, Gallacher J, Hood K, et al. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterol Motil. 2013;25(11):918– E704. doi: 10.1111/nmo.12219.

31. Crouzet L, Gaultier E, Del’Homme C, et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil. 2013;25(4):e272– e282. doi: 10.1111/nmo.12103.

32. Kunze WA, Mao YK, Wang BX, et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med. 2009;13(8b):2261–2270. doi: 10.1111/j.1582-4934.2009.00686.x.

33. Iyer LM, Aravind L, Coon SL, et al. Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends Genet. 2004;20(7):292–299. doi: 10.1016/j.tig2004.05.007.

34. Asano Y, Hiramoto T, Nishino R, et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol. 2012;303(11):G1288–1295. doi: 10.1152/ajpgi.00341.2012.

35. Sobko T, Huang LY, Midtvedt T, et al. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med. 2006;41(6):985–991. doi: 10.1016/j.freeradbiomed.2006.06.020.

36. Schicho R, Krueger D, Zeller F, et al. Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea-pig and human colon. Gastroenterology. 2006;131(5):1542–1552. doi: 10.1053/j. gastro.2006.08.035.

37. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses. 2003;61(5-6):519–525. doi: 10.1016/S0306-9877(03)00207-X.

38. Appel E, Kolman O, Kazimirsky G, et al. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. Neuroreport. 1997;8(15):3309–3312. doi: 10.1097/00001756-199710200-00023.

39. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003;54(1):70–75. doi: 10.1016/S0006-3223(03)00181-1.

40. Kimura I, Inoue D, Maeda T, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A. 2011;108(19):8030–8035. doi: 10.1073/pnas.1016088108.

41. Grider JR, Piland BE. The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF. Am J Physiol Gastrointest Liver Physiol. 2007;292(1):G429–G437. doi: 10.1152/ajpgi.00376.2006.

42. Vecsey CG, Hawk JD, Lattal KM, et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation. J Neurosci. 2007;27(23):6128– 6140. doi: 10.1523/Jneurosci.0296-07.2007.

43. Stefanko DP, Barrett RM, Ly AR, et al. Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci U S A. 2009;106(23):9447–9452. doi: 10.1073/pnas.0903964106.

44. Gecse K, Roka R, Ferrier L, et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 2008;57(5):591–599. doi: 10.1136/gut.2007.140210.

45. Carroll IM, Ringel-Kulka T, Ferrier L, et al. Fecal protease activity is associated with compositional alterations in the intestinal microbiota. PLoS One. 2013;8(10):e78017. doi: 10.1371/journal.pone.0078017.

46. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136(6):2003–2014. doi: 10.1053/j. gastro.2009.01.075.

47. Theodorou V, Ait Belgnaoui A, Agostini S, Eutamene H. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes. 2014;5(3):430–436. doi: 10.4161/ gmic.29796.

48. Uribe A, Alam M, Johansson O, et al. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology. 1994;107(5):1259–1269. doi: 10.1016/0016-5085(94)90526-6.

49. Tortorella C, Neri G, Nussdorfer GG. Galanin in the regulation of the hypothalamic-pituitary-adrenal axis (Review). Int J Mol Med. 2007;19(4):639–647. doi: 10.3892/ijmm.19.4.639.

50. Giordano R, Pellegrino M, Picu A, et al. Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA- , mineralocorticoid-, and GH-Secretagogue-receptor modulation. Scientific World Journal. 2006;6:1–11. doi: 10.1100/ tsw.2006.09.

51. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126(3):e526–e533. doi: 10.1542/ peds.2010-0433.

52. Indrio F, Riezzo G, Raimondi F, et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest. 2011;41(4):417–422. doi: 10.1111/j.1365-2362.2010.02425.x.

53. Coccorullo P, Strisciuglio C, Martinelli M, et al. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr. 2010;157(4):598–602. doi: 10.1016/j.jpeds.2010.04.066.

54. Romano C, Ferrau’ V, Cavataio F, et al. Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health. 2014;50(10):E68–71. doi: 10.1111/j.1440-1754.2010.01797.x.

55. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics. 2005;115(1):5–9. doi: 10.1542/peds.2004-1815.

56. Корниенко Е.А., Вагеманс Н.В., Нетребенко О.К. Младенческие кишечные колики: современные представления о механизмах развития и новые возможности терапии // Современная педиатрия. — 2010. — №5 — С. 176–183. [Kornienko EA, Vagemans NV, Netrebenko OK. Infant intestial colics: the modern view about mechanisms of development and new abilities of treatment. Sovremennaya pediatriya. 2010;(5):176–183. (In Russ).]

57. Schaefer L, Auchtung T, Hermans K, et al. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology. 2010;156(Pt 6):1589– 1599. doi: 10.1099/mic.0.035642-0.

58. Нетребенко О.К., Корниенко Е.А., Кубалова С.С. Использование пробиотиков у детей с младенческими коликами // Педиатрия. Журнал имени Г.Н. Сперанского. — 2014. — Т.93. — №4 — С. 86–93. [Netrebenko OK, Kornienko EA, Kubalova SS. Ispol’zovanie probiotikov u detei s mladencheskimi kolikami. Pediatriia. 2014;93(4):86–93. (In Russ).]

59. Valeur N, Engel P, Carbajal N, et al. Colonization and immuno-modulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 2004;70(2):1176–1181. doi: 10.1128/Aem.70.2.1176-1181.2004.

60. Jakobsson T, Abrahamsson T, Blörgsten B, et al. The effect of oral supplementation of Lactobacillus reuteri, on the immunologic composition of breast milk: OP4-05. J Pediatr Gastroenterol Nutr. 2005;40(5):624. doi: 10.1097/00005176-200505000-00042.

61. Gabriela Bergonzelli Degonda (Bussigny), Magali Faure (Forel), Nicole Kusy (Montet). Lactobacillus Reuteri DSM 17938 for the Development of the Enteric Nervous System Patent Application (Application #20140363409); EP20110196138 20111230; Dec 11, 2014.

62. Kamiya T, Wang L, Forsythe P, et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut. 2006;55(2):191–196. doi: 10.1136/ gut.2005.070987.

63. Savino F, Pelle E, Palumeri E et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007;119(1):e124–130. doi: 10.1542/peds.2006-1222.

64. wpengine.net [Internet]. Cabana MD, Chau K, D’Amico FJ, et al. Is Lactobacillus reuteri DSM 17938 effective for the treatment of infant colic? Results from an International Individual Participant Data Meta-Analysis (IPDMA). Murdoch Childrens Research Institute and The Royal Children’s Hospital Centre for Community Child Health [cited 2017 Aug 29]. Available from: http://4cau4jsaler1zglkq3wnmje1. wpengine.netdna-cdn.com/wp-content/uploads/2016/06/group-1-approved.pdf.

65. Cruchet S, Furnes R, Maruy A, et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Pediatric Drugs. 2015;17(3):199–216. doi: 10.1007/s40272-015-0124-6.


Для цитирования:


Макарова Е.Г., Украинцев С.Е. Функциональные расстройства органов пищеварения у детей: отдаленные последствия и современные возможности предупреждения и коррекции. Педиатрическая фармакология. 2017;14(5):392-399. https://doi.org/10.15690/pf.v14i5.1788

For citation:


Makarova E.G., Ukraintsev S.E. Functional Gastrointestinal Disorders in Infants: Long-Tern Consequences and Modern Approaches for Prevention and Treatment. Pediatric pharmacology. 2017;14(5):392-399. (In Russ.) https://doi.org/10.15690/pf.v14i5.1788

Просмотров: 234


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)